Trials / Terminated
TerminatedNCT02393573
Attenuating The Post-Operative Insulin Resistance And Promoting Protein Anabolism
Attenuating The Post-Operative Insulin Resistance And Promoting Protein Anabolism In Patients Undergoing Major Lung or Abdominal Surgery
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 7 (actual)
- Sponsor
- McGill University Health Centre/Research Institute of the McGill University Health Centre · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Major surgery results in a stress- induced catabolic response, marked by post-operative insulin resistance, hyperglycemia and loss of body protein, which is associated with increased morbidity, mortality and adverse outcomes. There has been a great deal of research on different approaches to optimize post-operative insulin sensitivity including hormonal and nutritional interventions, minimally invasive surgical techniques and epidural anesthesia. However, the correlation between insulin resistance and body protein loss is not well understood. Metformin is the most widely used insulin sensitizing and blood glucose-lowering drug in treatment of type 2 diabetic patients. This study will: 1) estimate the correlation between insulin resistance and body protein loss in pre-diabetic lung/colorectal resection patients; 2) investigate whether the post-operative metabolic state can be improved by the pre-operative administration of metformin; and assess the impact of metformin on surgical complications and hospital length of stay. The results of this study will provide insight into the relationship between insulin resistance and post-operative adverse events and potentially suggest a novel approach to improve outcomes using Metformin, a drug already in wide clinical use.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Metformin | Patients will take metformin for two weeks before Surgery and 2 days after the surgery |
| DRUG | Placebo | Patients will take Placebo pills for two weeks before Surgery and 2 days after the surgery |
Timeline
- Start date
- 2015-11-01
- Primary completion
- 2018-03-01
- Completion
- 2018-03-01
- First posted
- 2015-03-19
- Last updated
- 2018-03-23
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT02393573. Inclusion in this directory is not an endorsement.